This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovations of Robert Lai
Introduction
Robert Lai is an accomplished inventor based in Hatfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on PDE9 inhibitors. His expertise and dedication to research have led to the development of a notable patent that showcases his skills as an inventor.
Latest Patents
Robert Lai holds a patent for a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one or pharmaceutically acceptable salts thereof. This invention represents a significant advancement in the treatment options available for various medical conditions.
Career Highlights
Robert is currently employed at Eisai R&D Management Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapies that can improve patient outcomes. With a focus on innovation, Robert has established himself as a key player in the pharmaceutical industry.
Collaborations
Robert has collaborated with talented individuals such as Ishani Savant Landry and Mai Miyamoto. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the field of pharmaceuticals.
Conclusion
Robert Lai's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments, showcasing the impact of dedicated research and innovation.